Drug Profile
FBH 004
Alternative Names: Ebola (FBH-004); FBH-004Latest Information Update: 12 Sep 2023
Price :
$50
*
At a glance
- Originator Fabentech
- Class Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Ebola virus infections
Most Recent Events
- 12 Sep 2023 Discontinued - Preclinical for Ebola virus infections (Prevention) in France (Parenteral) (Fabentech pipeline, September 2023)
- 28 Aug 2020 No recent reports of development identified for preclinical development in Ebola-virus-infections(Prevention) in France (Parenteral)
- 22 Jul 2016 Preclinical trials in Ebola virus infections (Prevention) in France (Parenteral)